
AEHR TEST SYSTEMS
96
Recent developments include the release of Q3 2026 earnings results showing a net loss and missed revenue expectations, a fiscal year-end change, and an equity distribution agreement to raise capital. Market sentiment has been influenced by geopolitical events leading to stock price increases.
- AEHR TEST SYSTEMS reported Q3 2026 financial results with revenue of approximately $10.3 million and a net loss of $3.2 million for the quarter ended February 27, 2026 [S1].
- The company announced a change in its fiscal year end from May 31 to June 30 effective fiscal year 2027, with a 28-day transition period ending June 26, 2026 [S1].
- AEHR entered into an equity distribution agreement on April 8, 2026, to offer and sell up to $60 million of common stock under an effective registration statement [S1].
- Recent news highlights a sharp increase in AEHR’s stock price linked to easing geopolitical tensions and a US-Iran ceasefire, impacting market sentiment [N1][N2][N7][N8].
- Multiple earnings call transcripts from Q1 2025 through Q3 2026 have been published, providing detailed insights into financial results and business conditions [N3][N4][N5][N6].
AEHR TEST SYSTEMS is a California-based public company listed on NASDAQ under the ticker AEHR. The company has disclosed quarterly financial results through SEC filings and earnings call transcripts covering fiscal quarters from Q1 2025 through Q3 2026. It maintains a strong liquidity position with cash and equivalents of $36.9 million and current assets of $95.9 million against current liabilities of $8.7 million as of February 27, 2026. The company reported revenue of approximately $10.3 million and a net loss of $3.2 million for the same quarter. AEHR has recently amended its fiscal year end to June 30, effective fiscal year 2027, and has entered into an equity distribution agreement to offer up to $60 million in common stock. Public disclosures indicate no material changes to previously reported risk factors.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. AEHR TEST SYSTEMS reported $10.3 million in revenue and a net loss of $3.2 million for the quarter ended February 27, 2026, with strong liquidity ratios including a current ratio of 10.97 and cash ratio of 4.22 as of that date [S1].
AEHR TEST SYSTEMS demonstrates solid liquidity with a high current ratio and cash reserves, supporting operational stability. The company has access to capital through an equity distribution agreement, which may provide financial resources for growth or strategic initiatives. Recent earnings call transcripts suggest active management engagement and transparency. Market sentiment has shown positive reactions linked to broader geopolitical developments, potentially benefiting the company’s stock performance.
The company reported a net loss of $3.2 million for the quarter ended February 27, 2026, indicating ongoing profitability challenges. Revenue levels are modest at approximately $10.3 million for the same period. The absence of detailed business model disclosures and industry classification limits visibility into competitive positioning and growth drivers. Market volatility influenced by external geopolitical factors may impact stock price independently of company fundamentals. Risks detailed in the 2025 Annual Report remain relevant with no material changes reported.
The available information does not provide explicit details on AEHR TEST SYSTEMS' competitive advantages or moat. However, the company's ability to maintain strong liquidity and access capital markets through an equity distribution agreement suggests financial flexibility. The presence of multiple recent earnings call transcripts indicates ongoing investor communication and operational transparency, which may support business continuity. Specific technological or market differentiators are not detailed in the current disclosures.
• Profitability Risk: AEHR reported a net loss for the latest quarter, indicating challenges in achieving profitability.
• Revenue Concentration and Growth: Modest revenue levels and lack of detailed customer or product concentration disclosures may pose risks to sustained growth.
• Market and Geopolitical Sensitivity: Stock price movements have been influenced by external geopolitical events, which may introduce volatility unrelated to company fundamentals.
• Limited Business Model Disclosure: Public filings and disclosures provide limited detail on the company’s specific products, markets, and competitive advantages, reducing transparency.
Business trends: The company continues to report modest revenue with net losses, maintains strong liquidity, and experiences stock price volatility influenced by geopolitical developments.
Execution milestones: Completion of fiscal year-end change, publication of multiple quarterly earnings calls, and execution of an equity distribution agreement to raise capital.
Key risks: Profitability challenges, limited detailed business model disclosure, revenue concentration risks, and sensitivity to external market and geopolitical factors.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- AEHR TEST SYSTEMS is a publicly traded company on NASDAQ under the ticker AEHR.
- The company is incorporated in California, United States, with principal executive offices at 400 Kato Terrace, Fremont, CA.
- As of the quarter ended February 27, 2026, AEHR reported cash and cash equivalents of $36.9 million and current assets of $95.9 million, with current liabilities of $8.7 million, resulting in a strong current ratio of 10.97 and a cash ratio of 4.22, indicating solid liquidity.
- For the quarter ended February 27, 2026, AEHR reported revenue of approximately $10.3 million and a net loss of $3.2 million, with basic and diluted EPS of -$0.10 per share.
- The company announced a change in its fiscal year end from May 31 to June 30 effective fiscal year 2027, with a 28-day transition period ending June 26, 2026.
- AEHR entered into an equity distribution agreement on April 8, 2026, to offer and sell up to $60 million of common stock under an existing effective registration statement.
- Recent earnings call transcripts for Q1 2025 through Q3 2026 are publicly available, providing detailed discussions of financial results and business conditions.
- The company reported a Q3 2026 loss and missed revenue expectations as disclosed in a press release on April 7, 2026.
- No material changes to risk factors were reported since the Annual Report on Form 10-K for the year ended May 30, 2025, which details significant risks associated with the business.
- Recent news coverage highlights a sharp stock price increase linked to easing geopolitical tensions and a US-Iran ceasefire, impacting market sentiment around AEHR.
- The company operates in a technology-related sector, as inferred from the nature of earnings calls and product discussions, though specific industry classification is not detailed in the available data.
Generated 2026-04-09
- N3
- N4
- N5
- N6
- S1 | 2026-04-08 | 10-Q
- N1 | 2026-04-09 | www.nasdaq.com | Stocks Finish Sharply Higher on US-Iran Ceasefire | https://www.nasdaq.com/articles/stocks-finish-sharply-higher-us-iran-ceasefire
- N2 | 2026-04-09 | www.nasdaq.com | Why Aehr Test Systems Stock Skyrocketed Today | https://www.nasdaq.com/articles/why-aehr-test-systems-stock-skyrocketed-today
- N3 | 2026-04-08 | www.nasdaq.com | Aehr Test (AEHR) Q3 2025 Earnings Call Transcript | https://www.nasdaq.com/articles/aehr-test-aehr-q3-2025-earnings-call-transcript
- N4 | 2026-04-08 | www.nasdaq.com | Aehr Test (AEHR) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/aehr-test-aehr-q3-2026-earnings-call-transcript
- N5 | 2026-04-08 | www.nasdaq.com | Aehr Test (AEHR) Q2 2025 Earnings Call Transcript | https://www.nasdaq.com/articles/aehr-test-aehr-q2-2025-earnings-call-transcript
- N6 | 2026-04-08 | www.nasdaq.com | Aehr (AEHR) Q1 2025 Earnings Call Transcript | https://www.nasdaq.com/articles/aehr-aehr-q1-2025-earnings-call-transcript
- N7 | 2026-04-08 | www.nasdaq.com | Stocks Soar as US and Iran Agree to a Ceasefire | https://www.nasdaq.com/articles/stocks-soar-us-and-iran-agree-ceasefire
- N8 | 2026-04-08 | www.nasdaq.com | Easing Geopolitical Tensions Push Stocks Sharply Higher | https://www.nasdaq.com/articles/easing-geopolitical-tensions-push-stocks-sharply-higher
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


